Skip to search formSkip to main contentSkip to account menu

Cyclandelate

Known as: Benzeneacetic acid, alpha-hydroxy-, 3,3,5-trimethylcyclohexyl ester, 3,5,5-Trimethylcyclohexyl amygdalate, Cyclandelatum 
A direct-acting SMOOTH MUSCLE relaxant used to dilate BLOOD VESSELS.
National Institutes of Health

Related topics

Related topics

11 relations

Narrower (1)

Cyclospasmol
Drug AllergyIn BloodPeripheral Vascular Diseasesagonists

Broader (1)

Vasodilator Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Cyclandelate in the Prophylaxis of Migraine: A Placebo-Controlled Study
The prophylactic action of cyclandelate was investigated in a multicentre, randomized, placebo-controlled, parallel group study… 
1998
1998
Clinical efficacy and central mechanisms of cyclandelate in migraine: a double-blind placebo-controlled study.
The mechanisms of action of calcium antagonists in the prophylactic treatment of migraine remain unclear. The most likely… 
1995
1995
Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
The aim of the present study was to ascertain the comparative efficacy of cyclandelate, a migraine prophylactic with calcium… 
1978
1978
Cyclandelate in the Treatment of Senility: A Controlled Study
ABSTRACT: Elderly patients often manifest a variety of symptoms (e.g., depression, memory loss, irritability, hostility… 
1977
1977
Cyclandelate in the Treatment of Senile Mental Changes: A Double‐Blind Evaluation
The treatment of cerebrovascular insufficiency and its many symptoms in the ever‐increasing numbers of the aged, is of major… 
1976
1976
Cyclandelate in the Treatment of Cerebral Arteriosclerosis *
ABSTRACT: Twenty‐one patients with cerebral arteriosclerosis were treated for twelve months with placebo or cyclandelate… 
Highly Cited
1975
Highly Cited
1975
Some experience in interactive system development and application
Minicomputers pgoggammed in a high-level interactive language form a very attractive basis fog the development of systems… 
1974
1974
Treatment of the Cerebral Manifestations of Arteriosclerosis with Cyclandelate
Despite controversy about whether cerebral arteriosclerosis is a valid clinical entity and independent of senile dementia and/or… 
1970
1970
The effect of cyclandelate on mental function in patients with arteriosclerotic brain disease.
A double-blind crossover trial is described in which the effect of cyclandelate is assessed on 40 patients admitted to a… 
1967
1967
Effect of cyclandelate on mental function and cerebral blood flow in elderly patients.
There is no demonstrable impairment in the ability of the cerebral blood vessels of elderly subjects to dilate in response to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)